• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC GLUCOSE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC GLUCOSE Back to Search Results
Catalog Number 03L82-21
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/18/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported a falsely elevated architect glucose result fo a (b)(6) year old male patient.Sample id (b)(6) generated 19.91 mmol/l (358.74 mg/dl) and retest of 4.82 mmol/l (86.45 mg/dl).No impact to patient management was reported.
 
Manufacturer Narrative
Investigation of the issue included a review of the complaint text, a search for similar complaints, review of manufacturing documentation and labeling.Return testing was not completed as returns were not available.The customer analyzed the data and discovered their non-abbott ckmb resgent had interfered with the glucose assay as the ckmb reagent contained glucose.The customer adjusted the position of the two assays and subsequent testing was acceptable.Review of complaint activity found no other complaints for reagent lot 54493uq01.Tracking and trending report review for the architect glucose assay determined that there were no related trends.Manufacturing documentation including the certificate of analysis for the reagent lot was reviewed.This review found the lot was released within specifications and all abbott acceptance requirements were met.No issues were identified associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect glucose assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GLUCOSE
Type of Device
GLUCOSE
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
MDR Report Key9166317
MDR Text Key192387512
Report Number1628664-2019-00656
Device Sequence Number1
Product Code CFR
UDI-Device Identifier00380740006006
UDI-Public00380740006006
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/08/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2020
Device Catalogue Number03L82-21
Device Lot Number54493UQ01
Was Device Available for Evaluation? No
Date Manufacturer Received11/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT C16000 ANALYZER; ARCHITECT C16000 ANALYZER; LIST 03L77-01, SERIAL (B)(4); LIST 03L77-01, SERIAL (B)(4)
Patient Age30 YR
-
-